Using evidence and being open-minded are 2 strategies for providers shifting to new models of delivering care, says Lee A. Norman, MD, MHS, MBA, senior medical director for Optum Care Kansas City.
Using evidence and being open-minded are 2 strategies for providers shifting to new models of delivering care, says Lee A. Norman, MD, MHS, MBA, senior medical director for Optum Care Kansas City.
Transcript
What role can physicians play in driving innovation and leadership in health care, particularly when it comes to adopting new models of care?
The role of physicians in how to lead in a value-based care world is one that I think we really have to be creative and innovative, because we need better and stronger models for care. Physicians should be open-minded to looking at new and challenging different ways to do things. Sometimes it means, as I said earlier, using evidence to change our practices, because there are certain things, quite honestly, that don't work. And yet they're very traditionally implemented. And we see lots of those specifically, in neurologic situations. A lot of cardiac, a lot of excess imaging is done, that doesn't really have a payback in terms of the clinical quality.
And then finally, clinical quality indicators. The data is getting more robust all the time, and we need to pay attention to outcomes, and especially where there is disparities and outcomes, we have to understand why. B physicians can lead by being creative and innovative, and it's really important to be open-minded.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More